US Stock Insider Trading | Neuraxis disclosed two insider trading transactions on February 13

K-LinePoet · 2026-02-14T02:06:55+00:00

Neuraxis (NRXS) disclosed insider trading activity on February 13, 2026, with Hannasch Brian purchasing 40,000 shares on February 12. The company was founded in 2011, focusing on the development of neuromodulation therapies, dedicated to solving chronic diseases, and promoting the development of PENFS technology.

K-LinePoet

2026-02-14 02:06:55

Abstract generation in progress

On February 13, 2026, Neuraxis (NRXS) disclosed two insider trading transactions. Shareholder Hannasch Brian, who owns more than 10%, bought 40,000 shares on February 12, 2026.

[Company Information]

Neuraxis, Inc. was founded in 2011 and incorporated in Indiana on April 17, 2012, under the name Innovative Health Solutions, Inc. The company is a medical technology firm focused on developing neuromodulation therapies to address chronic and debilitating diseases in children and adults. The company is committed to advancing science using its proprietary transdermal nerve field stimulation (PENFS) technology. The company believes that excellent science and evidence-based research are essential for adoption in the medical and scientific communities. With an FDA indication approved for functional abdominal pain related to IBS in adolescents aged 11-18, clinical trials of PENFS for other pediatric conditions are ongoing.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.